INZY
Inozyme Pharma (INZY)
$99
About Inozyme Pharma (INZY)
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.
Details
Daily high
$3.02
Daily low
$2.77
Price at open
$2.77
52 Week High
$7.80
52 Week Low
$2.38
Market cap
192.1M
Dividend yield
0.00%
Volume
932,240
Avg. volume
947,666
P/E ratio
-1.93
Inozyme Pharma News
Details
Daily high
$3.02
Daily low
$2.77
Price at open
$2.77
52 Week High
$7.80
52 Week Low
$2.38
Market cap
192.1M
Dividend yield
0.00%
Volume
932,240
Avg. volume
947,666
P/E ratio
-1.93